New Data from Ulsan National Institute of Science and Technology (UNIST) Illuminate Findings in Diabetes Research (High-efficiency, Prevascularization-free Macroencapsulation System for Subcutaneous Transplantation of Pancreatic Islets for...).

A recent study conducted at the Ulsan National Institute of Science and Technology in South Korea has developed a high-efficiency, prevascularization-free macroencapsulation system for subcutaneous transplantation of pancreatic islets to treat Type I diabetes. This system, which involves a multilayer sheet design, has shown promising results in improving insulin secretion function and stabilizing blood glucose levels in diabetic mice. The research suggests that this macroencapsulation system could advance the treatment of Type I diabetes and potentially be effective for islet xenotransplantation in subcutaneous tissue. [Extracted from the article]